Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service.

Autor: Matta BP; Programa de Genética e Virologia Tumoral, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Gomes R; Programa de Genética e Virologia Tumoral, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Mattos D; Programa de Genética e Virologia Tumoral, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Olicio R; Programa de Genética e Virologia Tumoral, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Nascimento CM; Programa de Genética e Virologia Tumoral, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.; Programa de Pós-Graduação em Genética, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil., Ferreira GM; Centro de Transplante de Medula Óssea, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Brant AC; Programa de Genética e Virologia Tumoral, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.; Tumor Virus RNA Biology Section, HIV DRP, National Cancer Institute, NIH, Frederick, MD, USA., Boroni M; Laboratório de Bioinformática e Biologia Computacional, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Furtado C; Programa de Genética e Virologia Tumoral, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Lima V; Programa de Genética e Virologia Tumoral, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Moreira MÂM; Programa de Genética e Virologia Tumoral, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil., Dos Santos ACE; Programa de Genética e Virologia Tumoral, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil. acsantos@inca.gov.br.

Publikováno v: Scientific reports [Sci Rep] 2022 Nov 03; Vol. 12 (1), pp. 18629. Date of Electronic Publication: 2022 Nov 03.

A rapid method for detecting and distinguishing clinically important yeasts by Heteroduplex Mobility Assays (HMAs)

Autor: Olicio, R, Almeida, CAS, Seuánez, HN

Publikováno v: In Molecular and Cellular Probes August 1999 13(4):251-255

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Heteroduplex mobility assays (HMAs) and analogous sequence analysis of a cytochrome b region indicate phylogenetic relationships of selected callitrichids.

Autor: Moreira MA; Genetics Section, Instituto Nacional de Câncer, Praça da Cruz Vemelha, Rio de Janeiro, Brazil., Almeida CA, Canavez F, Olicio R, Seuánez HN

Publikováno v: The Journal of heredity [J Hered] 1996 Nov-Dec; Vol. 87 (6), pp. 456-60.

Genomic ancestry and cancer among Latin Americans.

Autor: Ruíz-Patiño A; Clinical Genetics, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia.; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia.; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia., Rojas L; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia.; Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia., Zuluaga J; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia.; Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia., Arrieta O; Instituto Nacional de Cancerología -INCaN, Mexico City, Mexico., Corrales L; Thoracic Oncology Unit, Centro de Investigación y Manejo del Cáncer (CIMCA), San José, Costa Rica., Martín C; Thoracic Oncology Unit, Instituto Alexander Fleming, Buenos Aires, Argentina., Franco S; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia.; Breast Cancer Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia., Raez L; Oncology Department, Memorial Cancer Institute (MCI), Memorial Healthcare System, Miami, FL, USA., Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sánchez N; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia.; Institute of Research, Science and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia., Cardona AF; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia. acardona@fctic.org.; Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia. acardona@fctic.org.; Institute of Research, Science and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia. acardona@fctic.org.; Direction of Research and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Cra. 14 #169-49, Bogotá, Colombia. acardona@fctic.org.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Aug; Vol. 26 (8), pp. 1856-1871. Date of Electronic Publication: 2024 Apr 06.